Tate & Lyle plc
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Tate & Lyle plc is a specialty food and beverage solutions company that manufactures and supplies a broad range of ingredients including sweeteners, functional starches, dietary fibers, and specialty food additives. The company operates through four core business segments: Food & Beverage Solutions, Sucralose, Primary Products Europe, and CP Kelco. Its product portfolio includes high-intensity sweeteners such as SPLENDA Sucralose and TASTEVA Stevia Sweetener; functional clean label starches like CLARIA; soluble fibers under PROMITOR; crystalline fructose branded as KRYSTAR; and nature-based ingredients such as pectin and specialty gums, primarily through its CP Kelco segment. Tate & Lyle serves global markets including beverages; dairy; soups, sauces, and dressings; bakery and snacks; confectionery; meat and seafood; personal care; household; clinical nutrition; and industrial applications. Founded in 1903 and headquartered in London, United Kingdom, Tate & Lyle has undergone significant transformation in recent years, focusing on becoming a growth-oriented specialty ingredient supplier. The most notable recent change is the acquisition of CP Kelco in June 2024, a major global provider of pectin and specialty gums, which expanded Tate & Lyle’s product and geographic reach significantly. This acquisition aligns with the company’s strategic emphasis on natural, sustainable ingredients and solution-based innovation. In addition, Tate & Lyle has increased investment in product innovation and capacity expansion to meet growing consumer demand for healthier, lower-calorie, and clean-label foods and beverages. Other recent operational moves include a £216 million share buyback funded by proceeds from divestments, signaling capital return discipline and confidence in ongoing strategic execution. Tate & Lyle’s specialty ingredients help customers reduce sugar and calories, enhance mouthfeel, and fortify products with dietary fiber and protein. The company actively pursues value-creative acquisitions and partnerships to strengthen its portfolio and capabilities in sensory applications and open innovation. With over 4,900 employees globally and operations in more than 60 locations worldwide, Tate & Lyle targets multiple consumer-focused industries with a clear business model centered on specialty food ingredients and solutions for health-conscious consumer trends.
Ingredion to Take Over Tate & Lyle in $3.6 Billion Deal
Tate & Lyle agrees £3.8bn takeover by US rival
Ingredion Announces Recommended All-Cash Acquisition of Tate & Lyle
UK's Tate & Lyle agrees $3.6 billion Ingredion takeover
Tate & Lyle plc (TATYY) Q4 2026 Earnings Call Transcript
Tate & Lyle H2 Earnings Call Highlights
Ingredion Takeover Target Tate & Lyle Posts Fall in Profit
BioHarvest Sciences and Tate & Lyle expand sweetener development program
Tate & Lyle is a sweet opportunity for bidders says broker
Tate & Lyle In Talks With Ingredion Over $3.7 billion Takeover Offer
Britain's Tate & Lyle in discussions with US rival Ingredion for $3.7 billion takeover bid
Tate & Lyle (OTCMKTS:TATYY) Shares Gap Up – Should You Buy?
Critical Contrast: Armanino Foods of Distinction (OTCMKTS:AMNF) & Tate & Lyle (OTCMKTS:TATYY)
Tate & Lyle (OTCMKTS:TATYY) versus Kraft Heinz (NASDAQ:KHC) Head-To-Head Survey
Head to Head Contrast: Ingredion (NYSE:INGR) and Tate & Lyle (OTCMKTS:TATYY)
Tate & Lyle (OTCMKTS:TATYY) Shares Gap Down – Should You Sell?
Tate & Lyle plc (TATYY) Q3 2026 Earnings Call Transcript
Tate & Lyle PLC (OTCMKTS:TATYY) Given Average Recommendation of “Hold” by Analysts
Reviewing Tate & Lyle (OTCMKTS:TATYY) and Greenlane (NASDAQ:GNLN)
Tate & Lyle PLC (OTCMKTS:TATYY) Receives Average Rating of “Hold” from Analysts